Shire

Shire

Verified
Global Innovator in Specialty Biopharmaceuticals

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-1m2m2m---
% growth--100 %----
EBITDA-1m2m2m---
% EBITDA margin-100 %100 %100 %---
R&D budget1.3b1.4b-----
R&D % of revenue-143100 %-----

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
*
$5.9b
Valuation: $5.9b
Acquisition
Total Funding-

Recent News about Shire

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Shire

Edit
Foresight Biotherapeutics
ACQUISITION by Shire Aug 2015
ArmaGen Technologies
ACQUISITION by JCR Pharmaceuticals Mar 2020
New River Pharmaceuticals
ACQUISITION by Shire Apr 2007
Naurex
ACQUISITION by Allergan Jul 2015
Lumena Pharmaceuticals
ACQUISITION by Shire May 2014
ViroPharma
ACQUISITION by Shire Nov 2013
Movetis
ACQUISITION by Shire Aug 2010
Meritage Pharma
ACQUISITION by Shire Feb 2015
View 12 more